Section 503A, in turn, allows for patient-specific compounding performed by (1) a licensed pharmacist in a state-licensed pharmacy or federal facility, or (2) a licensed physician for example, for patients who are allergic to certain inactive ingredients, need a liquid formulation rather than a pill, or need a lower strength than what is commercially available The Rise and Fall of GLP-1 Compounding As we detailed here, compounding pharmacies entered the GLP-1 market in 2022 when demand for semaglutide and tirzepatide outstripped supply and both drugs hit the FDA Drug Shortage List, resulting in the emergence of a multibillion-dollar sub-industry
Even for patients who fit the appropriate FDA criteria, a rise in online prescribing and doctor shopping is leading to patients missing the care coordination necessary for successful outcomes
Avoid candy, pastries, regular desserts, and other sweets that provide only sugar without protein
It is an easy and pain-free method of taking medication
Ruiz continued
